Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? (Q35981002)

11 August 2017

1 reference

title

Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? (English)

1 reference

11 August 2017

0 references

1 reference

1 reference

1 reference

A A Tahrani

1

1 reference

11 August 2017

G I Varughese

series ordinal

2

1 reference

11 August 2017

J H Scarpello

series ordinal

3

1 reference

11 August 2017

F W F Hanna

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

11 August 2017

1 reference

11 August 2017

335

1 reference

11 August 2017

508-512

1 reference

11 August 2017

7618

1 reference

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Metformin and lactic acidosis: cause or coincidence? A review of case reports

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Review of management of type 2 diabetes mellitus.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Patients with Type 2 diabetes treated with metformin: prevalence of contraindications and their correlation with discontinuation

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Frequency of inappropriate metformin prescriptions

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Contra-indications to metformin therapy are largely disregarded

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

Lactic acidosis rates in type 2 diabetes.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971167

The incidence of congestive heart failure in type 2 diabetes: an update

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17823192

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Contraindications to metformin therapy in patients with NIDDM

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17823192

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17823192

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.39255.669444.AE

1 reference

11 August 2017

1 reference

11 August 2017

1 reference